Deal Quality
655 deals scored · avg quality 73.3/100 · A:313 B:338 C:4 D:0 · 41 flagged
🛡️ Public data only — no PHI permitted on this instance.
Total Deals
655
in corpus
Avg Quality
73.3
out of 100
Tier A
313
48% of corpus
Tier B
338
52% of corpus
Flagged
41
4 errors total
Quality Distribution
Tier Breakdown
A≥75 · B≥55 · C≥35 · D<35 | composite = 55% completeness + 45% credibility
Score Histogram (0–100)
Filter & Sort
Showing 38 of 338 deals
· p.7/7
Per-Deal Quality Scores — 38 of 338
| ID | Deal | Tier | Score | Completeness | Credibility | Flags | Missing Fields |
|---|---|---|---|---|---|---|---|
| seed_293 | B | 64.2 | 35% | 100% | — | sector, ebitda_at_entry_mm, ebitda_mm, ev_ebitda, revenue_mm… | |
| seed_300 | B | 64.2 | 35% | 100% | — | sector, ebitda_at_entry_mm, ebitda_mm, ev_ebitda, revenue_mm… | |
| seed_305 | B | 64.2 | 35% | 100% | — | sector, ebitda_at_entry_mm, ebitda_mm, ev_ebitda, revenue_mm… | |
| seed_311 | B | 64.2 | 35% | 100% | — | sector, ebitda_at_entry_mm, ebitda_mm, ev_ebitda, revenue_mm… | |
| seed_312 | B | 64.2 | 35% | 100% | — | sector, ebitda_at_entry_mm, ebitda_mm, ev_ebitda, revenue_mm… | |
| seed_315 | B | 64.2 | 35% | 100% | — | sector, ebitda_at_entry_mm, ebitda_mm, ev_ebitda, revenue_mm… | |
| seed_198 | B | 62.6 | 32% | 100% | — | sector, ebitda_at_entry_mm, ebitda_mm, ev_ebitda, revenue_mm… | |
| seed_215 | B | 62.6 | 32% | 100% | — | sector, ebitda_at_entry_mm, ebitda_mm, ev_ebitda, revenue_mm… | |
| seed_271 | B | 62.6 | 32% | 100% | — | sector, ebitda_at_entry_mm, ebitda_mm, ev_ebitda, revenue_mm… | |
| seed_072 | B | 62.3 | 38% | 92% | WRN EV/EBITDA=57.8x outside 2–40× typical healthcare PE | sector, ebitda_mm, ev_ebitda, deal_type, region… | |
| seed_082 | B | 62.3 | 38% | 92% | WRN EV/EBITDA=-15.0x outside 2–40× typical healthcare PE | sector, ebitda_mm, ev_ebitda, deal_type, region… | |
| seed_092 | B | 62.3 | 38% | 92% | WRN EV/EBITDA=-15.0x outside 2–40× typical healthcare PE | sector, ebitda_mm, ev_ebitda, deal_type, region… | |
| seed_096 | B | 62.3 | 38% | 92% | WRN EV/EBITDA=-154.2x outside 2–40× typical healthcare PE | sector, ebitda_mm, ev_ebitda, deal_type, region… | |
| seed_098 | B | 62.3 | 38% | 92% | WRN EV/EBITDA=-23.3x outside 2–40× typical healthcare PE | sector, ebitda_mm, ev_ebitda, deal_type, region… | |
| seed_099 | B | 62.3 | 38% | 92% | WRN EV/EBITDA=60.0x outside 2–40× typical healthcare PE | sector, ebitda_mm, ev_ebitda, deal_type, region… | |
| seed_101 | B | 62.3 | 38% | 92% | WRN EV/EBITDA=124.7x outside 2–40× typical healthcare PE | sector, ebitda_mm, ev_ebitda, deal_type, region… | |
| seed_120 | B | 62.3 | 38% | 92% | WRN EV/EBITDA=114.3x outside 2–40× typical healthcare PE | sector, ebitda_mm, ev_ebitda, deal_type, region… | |
| seed_121 | B | 62.3 | 38% | 92% | WRN EV/EBITDA=-68.2x outside 2–40× typical healthcare PE | sector, ebitda_mm, ev_ebitda, deal_type, region… | |
| seed_123 | B | 62.3 | 38% | 92% | WRN EV/EBITDA=-104.8x outside 2–40× typical healthcare PE | sector, ebitda_mm, ev_ebitda, deal_type, region… | |
| seed_125 | B | 62.3 | 38% | 92% | WRN EV/EBITDA=-58.5x outside 2–40× typical healthcare PE | sector, ebitda_mm, ev_ebitda, deal_type, region… | |
| seed_130 | B | 62.3 | 38% | 92% | WRN EV/EBITDA=-36.4x outside 2–40× typical healthcare PE | sector, ebitda_mm, ev_ebitda, deal_type, region… | |
| seed_131 | B | 62.3 | 38% | 92% | WRN EV/EBITDA=-3.8x outside 2–40× typical healthcare PE | sector, ebitda_mm, ev_ebitda, deal_type, region… | |
| seed_139 | B | 62.3 | 38% | 92% | WRN EV/EBITDA=-55.0x outside 2–40× typical healthcare PE | sector, ebitda_mm, ev_ebitda, deal_type, region… | |
| seed_147 | B | 62.3 | 38% | 92% | WRN EV/EBITDA=-15.5x outside 2–40× typical healthcare PE | sector, ebitda_mm, ev_ebitda, deal_type, region… | |
| seed_163 | B | 62.3 | 38% | 92% | WRN EV/EBITDA=-23.3x outside 2–40× typical healthcare PE | sector, ebitda_mm, ev_ebitda, deal_type, region… | |
| seed_167 | B | 62.3 | 38% | 92% | WRN EV/EBITDA=-6.7x outside 2–40× typical healthcare PE | sector, ebitda_mm, ev_ebitda, deal_type, region… | |
| seed_171 | B | 62.3 | 38% | 92% | WRN EV/EBITDA=-44.0x outside 2–40× typical healthcare PE | sector, ebitda_mm, ev_ebitda, deal_type, region… | |
| seed_179 | B | 62.3 | 38% | 92% | WRN EV/EBITDA=-62.5x outside 2–40× typical healthcare PE | sector, ebitda_mm, ev_ebitda, deal_type, region… | |
| seed_182 | B | 62.3 | 38% | 92% | WRN EV/EBITDA=-24.0x outside 2–40× typical healthcare PE | sector, ebitda_mm, ev_ebitda, deal_type, region… | |
| seed_185 | B | 62.3 | 38% | 92% | WRN EV/EBITDA=-43.3x outside 2–40× typical healthcare PE | sector, ebitda_mm, ev_ebitda, deal_type, region… | |
| seed_186 | B | 62.3 | 38% | 92% | WRN EV/EBITDA=-50.0x outside 2–40× typical healthcare PE | sector, ebitda_mm, ev_ebitda, deal_type, region… | |
| seed_187 | B | 62.3 | 38% | 92% | WRN EV/EBITDA=44.4x outside 2–40× typical healthcare PE | sector, ebitda_mm, ev_ebitda, deal_type, region… | |
| seed_190 | B | 62.3 | 38% | 92% | WRN EV/EBITDA=-35.5x outside 2–40× typical healthcare PE | sector, ebitda_mm, ev_ebitda, deal_type, region… | |
| seed_191 | B | 62.3 | 38% | 92% | WRN EV/EBITDA=63.5x outside 2–40× typical healthcare PE | sector, ebitda_mm, ev_ebitda, deal_type, region… | |
| seed_193 | B | 62.3 | 38% | 92% | WRN EV/EBITDA=-44.0x outside 2–40× typical healthcare PE | sector, ebitda_mm, ev_ebitda, deal_type, region… | |
| seed_195 | B | 62.3 | 38% | 92% | WRN EV/EBITDA=-31.7x outside 2–40× typical healthcare PE | sector, ebitda_mm, ev_ebitda, deal_type, region… | |
| seed_075 | B | 56.0 | 20% | 100% | — | sector, ebitda_at_entry_mm, ebitda_mm, ev_ebitda, deal_type… | |
| seed_146 | B | 56.0 | 20% | 100% | — | sector, ebitda_at_entry_mm, ebitda_mm, ev_ebitda, deal_type… |
Scoring Methodology
Completeness (55% weight)
| sector | 20 pts |
| ebitda_at_entry_mm | 18 pts |
| year | 10 pts |
| source | 8 pts |
| ebitda_mm / ev_ebitda | 8 / 7 pts |
| deal_type / region / revenue | 6 / 6 / 5 pts |
| geography / state / leverage / notes | 4/3/3/2 pts |
Credibility (45% weight)
| Start score | 100 |
| MOIC ≤ 0 (error) | −30 |
| IRR < −100% (error) | −20 |
| EV ≤ 0 (error) | −25 |
| Hold ≤ 0 (error) | −15 |
| MOIC/IRR mismatch >25pp | −10 |
| EV/EBITDA outside 2–40× | −8 |